These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21990315)

  • 1. Na(+)/H(+) exchanger regulatory factor 1 (NHERF1) is required for the estradiol-dependent increase of phosphatase and tensin homolog (PTEN) protein expression.
    Yang L; Wang Y; Chen P; Hu J; Xiong Y; Feng D; Liu H; Zhang H; Yang H; He J
    Endocrinology; 2011 Dec; 152(12):4537-49. PubMed ID: 21990315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatase and tensin homolog deleted on chromosome 10 degradation induced by NEDD4 promotes acquired erlotinib resistance in non-small-cell lung cancer.
    Sun H; Ma H; Wang J; Xia L; Zhu G; Wang Z; Sun J; Chen Z
    Tumour Biol; 2017 Jul; 39(7):1010428317709639. PubMed ID: 28714370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.
    Pan Y; Weinman EJ; Dai JL
    Breast Cancer Res; 2008; 10(1):R5. PubMed ID: 18190691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crucial role of the C-terminus of PTEN in antagonizing NEDD4-1-mediated PTEN ubiquitination and degradation.
    Wang X; Shi Y; Wang J; Huang G; Jiang X
    Biochem J; 2008 Sep; 414(2):221-9. PubMed ID: 18498243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NHERF1 regulates actin cytoskeleton organization through modulation of α-actinin-4 stability.
    Sun L; Zheng J; Wang Q; Song R; Liu H; Meng R; Tao T; Si Y; Jiang W; He J
    FASEB J; 2016 Feb; 30(2):578-89. PubMed ID: 26432781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling.
    Cheng S; Li Y; Yang Y; Feng D; Yang L; Ma Q; Zheng S; Meng R; Wang S; Wang S; Jiang WG; He J
    FEBS Lett; 2013 Oct; 587(20):3289-95. PubMed ID: 24012959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma.
    Molina JR; Agarwal NK; Morales FC; Hayashi Y; Aldape KD; Cote G; Georgescu MM
    Oncogene; 2012 Mar; 31(10):1264-74. PubMed ID: 21804599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatase and tensin homolog regulates stability and activity of EphB1 receptor.
    Rodriguez S; Huynh-Do U
    FASEB J; 2013 Feb; 27(2):632-44. PubMed ID: 23118026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer.
    Meng R; Qin Q; Xiong Y; Wang Y; Zheng J; Zhao Y; Tao T; Wang Q; Liu H; Wang S; Jiang WG; He J
    Oncotarget; 2016 Aug; 7(34):54983-54997. PubMed ID: 27448983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4.
    Ahn Y; Hwang CY; Lee SR; Kwon KS; Lee C
    Biochem J; 2008 Jun; 412(2):331-8. PubMed ID: 18307411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The scaffolding protein NHERF1 sensitizes EGFR-dependent tumor growth, motility and invadopodia function to gefitinib treatment in breast cancer cells.
    Bellizzi A; Greco MR; Rubino R; Paradiso A; Forciniti S; Zeeberg K; Cardone RA; Reshkin SJ
    Int J Oncol; 2015 Mar; 46(3):1214-24. PubMed ID: 25530180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling.
    Takahashi Y; Morales FC; Kreimann EL; Georgescu MM
    EMBO J; 2006 Feb; 25(4):910-20. PubMed ID: 16456542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NEDD4 is overexpressed in colorectal cancer and promotes colonic cell growth independently of the PI3K/PTEN/AKT pathway.
    Eide PW; Cekaite L; Danielsen SA; Eilertsen IA; Kjenseth A; Fykerud TA; Ågesen TH; Bruun J; Rivedal E; Lothe RA; Leithe E
    Cell Signal; 2013 Jan; 25(1):12-8. PubMed ID: 22974840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NHERF1: molecular brake on the PI3K pathway in breast cancer.
    Georgescu MM
    Breast Cancer Res; 2008; 10(2):106. PubMed ID: 18430260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NHERF1/EBP50 head-to-tail intramolecular interaction masks association with PDZ domain ligands.
    Morales FC; Takahashi Y; Momin S; Adams H; Chen X; Georgescu MM
    Mol Cell Biol; 2007 Apr; 27(7):2527-37. PubMed ID: 17242191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1).
    Pan Y; Wang L; Dai JL
    Breast Cancer Res; 2006; 8(6):R63. PubMed ID: 17078868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Na+/H+ exchanger regulatory factor 1 in forward trafficking of the type IIa Na+-Pi cotransporter.
    Ketchem CJ; Khundmiri SJ; Gaweda AE; Murray R; Clark BJ; Weinman EJ; Lederer ED
    Am J Physiol Renal Physiol; 2015 Jul; 309(2):F109-19. PubMed ID: 25995109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel NHERF1 Mutation in Human Breast Cancer Inactivates Inhibition by NHERF1 Protein in EGFR Signaling.
    DU G; Hao C; Gu Y; Wang Z; Jiang WG; He J; Cheng S
    Anticancer Res; 2016 Mar; 36(3):1165-73. PubMed ID: 26977012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulatory roles of NHERF1 and NHERF2 in cell surface expression of the glutamate transporter GLAST.
    Sato K; Otsu W; Otsuka Y; Inaba M
    Biochem Biophys Res Commun; 2013 Jan; 430(2):839-45. PubMed ID: 23200831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of E3 ligase NEDD4 in peripheral neurons interrupts axon outgrowth: Linkage to PTEN.
    Christie KJ; Martinez JA; Zochodne DW
    Mol Cell Neurosci; 2012 Jun; 50(2):179-92. PubMed ID: 22561198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.